Seattle Genetics (SGEN)
Awaiting an FDA announcement on Aug. 30 on the approval (or not) of the company's lymphoma drug Adcetris.Year to date performance: Flat Performance since June 30: -26% It looks like hedge funds were selling Seattle Genetics, perhaps because the stock's valuation ran up significantly ahead of the FDA's drug approval decision. Healthcor Management, Renaissance Technologies and Moore Capital Management were among the funds lightening their Seattle Genetics's positions in the second quarter. Citadel Advisors and Fortis Investments both added relatively small amounts of shares to existing positions. Baker Brothers kept its big 19.28 million-share stake in Seattle Genetics stable during the quarter.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV